MENU

DCOY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Decoy Therapeutics (DCOY) Ownership - Who owns Decoy Therapeutics?

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

3.23M

P/E Ratio

0.06

Total Cash

7.82M

Projected Growth

N/A

Total Debt

112.23K

Revenue

N/A

Risk (Beta)

0.97

Dividend Yield

N/A

Total Cash/Share

14.70

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

DCOY

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for DCOY

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details